Search research articles
Contact Us
Filters
Showing results (241-250 of 272) with videos related to
Page
of 28
Sort By:
Urologia Internationalis
|
August 28, 2018
Evaluation of Transperineal Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Compared to Transrectal Systematic Biopsy in the Prediction of Tumour Aggressiveness in Patients with Previously Negative Biopsy
Angelika Borkowetz, Theresa Renner, Ivan Platzek, et al.
Journal of Cellular Biochemistry
|
February 24, 2011
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
Sylvia Thiele, Martina Rauner, Claudia Goettsch, et al.
Urologia Internationalis
|
January 18, 2018
Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy
Angelika Borkowetz, Theresa Renner, Ivan Platzek, et al.
International Journal of Cancer
|
January 4, 2012
CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases
Daniela Wuttig, Stefan Zastrow, Susanne Füssel, et al.
The Canadian Journal of Urology
|
June 19, 2012
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases
Ulf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, et al.
BMC Cancer
|
September 4, 2014
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
Tilman D Rachner, Stefanie Thiele, Andy Göbel, et al.
European Urology Oncology
|
June 16, 2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
Stephen B Williams, Mohamed D Ray-Zack, Hogan K Hudgins, et al.
BMC Cancer
|
December 19, 2014
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
Susanne Fuessel, Kati Erdmann, Helge Taubert, et al.
European Urology
|
January 26, 2021
Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians
Axel S Merseburger, Nick Waldron, Maria J Ribal, et al.
Oncotarget
|
June 23, 2018
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
Stefanie Thiele, Ariane Zimmer, Andy Göbel, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 272) with videos related to
Sort By:
Page
of 28
Urologia Internationalis
|
August 28, 2018
Evaluation of Transperineal Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy Compared to Transrectal Systematic Biopsy in the Prediction of Tumour Aggressiveness in Patients with Previously Negative Biopsy
Angelika Borkowetz, Theresa Renner, Ivan Platzek, et al.
Journal of Cellular Biochemistry
|
February 24, 2011
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates
Sylvia Thiele, Martina Rauner, Claudia Goettsch, et al.
Urologia Internationalis
|
January 18, 2018
Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy
Angelika Borkowetz, Theresa Renner, Ivan Platzek, et al.
International Journal of Cancer
|
January 4, 2012
CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases
Daniela Wuttig, Stefan Zastrow, Susanne Füssel, et al.
The Canadian Journal of Urology
|
June 19, 2012
Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases
Ulf W Tunn, Amulf Stenzl, Wolfgang Schultze-Seemann, et al.
BMC Cancer
|
September 4, 2014
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients
Tilman D Rachner, Stefanie Thiele, Andy Göbel, et al.
European Urology Oncology
|
June 16, 2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
Stephen B Williams, Mohamed D Ray-Zack, Hogan K Hudgins, et al.
BMC Cancer
|
December 19, 2014
Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis
Susanne Fuessel, Kati Erdmann, Helge Taubert, et al.
European Urology
|
January 26, 2021
Genomic Testing in Patients with Metastatic Castration-resistant Prostate Cancer: A Pragmatic Guide for Clinicians
Axel S Merseburger, Nick Waldron, Maria J Ribal, et al.
Oncotarget
|
June 23, 2018
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells
Stefanie Thiele, Ariane Zimmer, Andy Göbel, et al.
Page
of 28